GGrantIndex
← Leaderboards

Dale L Greiner

Univ Of Massachusetts Med Sch Worcester

Google Scholar ↗PubMed ↗ORCID ↗
$17,425,144
Attributed
$39,517,997
Total exposure
20
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $7.8M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$48,652,793 · 21

By mechanism

U01$14,894,473 · 3
P01$12,999,112 · 7
R24$8,980,338 · 3
R01$5,948,562 · 5
UC4$4,109,951 · 1
P30$1,235,878 · 1

Top collaborators

Most similar at Univ Of Massachusetts Med Sch Worcester

Same institution · by research overlap

Others in their field

Top investigators on “Cells”

Research focus

CellsIn VivoBaseAnimal ModelImmuneResearch PersonnelLaboratoriesBeta CellImmune SystemVirusVirus DiseasesDiabetes MellitusNew TechnologyIsletMouse ModelTransplantationTechnologyEngraftmentResourcesProgramsResponseTissuesInfectionReagent

Grant awards (77)

Novel Humanized Mouse Models For Engraftment of Tissue-Specific Human Macrophage Population$846,948
R24 · FY2025 · OD
Novel Humanized Mouse Models For Engraftment of Tissue-Specific Human Macrophage Population$881,450
R24 · FY2024 · OD
Humanized Mouse Avatars for T1D$425,000
U01 · FY2023 · DK · contact PI
Humanized Mouse Avatars for T1D$1,005,973
U01 · FY2022 · DK · contact PI
Immunogenicity of Human Stem Cell-Derived Beta Cells and Muscle Cells in Humanized Mice$823,750
R24 · FY2022 · OD · contact PI
Humanized Mouse Avatars for T1D$1,008,786
U01 · FY2021 · DK · contact PI
Immunogenicity of Human Stem Cell-Derived Beta Cells and Muscle Cells in Humanized Mice$823,750
R24 · FY2021 · OD · contact PI
Live imaging of SARS-CoV-2 infection in novel humanized mice$499,998
R24 · FY2021 · OD · contact PI
Humanized Mouse Avatars for T1D$1,011,466
U01 · FY2020 · DK · contact PI
Immunogenicity of Human Stem Cell-Derived Beta Cells and Muscle Cells in Humanized Mice$823,750
R24 · FY2020 · OD · contact PI
Humanized mice for investigating human stem cell-derived microglia in Alzheimers Disease$420,750
R24 · FY2020 · OD · contact PI
Humanized Mouse Avatars for T1D$1,064,644
U01 · FY2019 · DK · contact PI
Immunogenicity of Human Stem Cell-Derived Beta Cells and Muscle Cells in Humanized Mice$840,625
R24 · FY2019 · OD · contact PI
Stage-specific Beta Cell Response and Biomarker Profile During Virus-induced T1D$376,875
R01 · FY2019 · DK · contact PI
Stage-specific Beta Cell Response and Biomarker Profile During Virus-induced T1D$376,875
R01 · FY2018 · DK · contact PI
Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy$725,922
R24 · FY2017 · OD · contact PI
Stage-specific Beta Cell Response and Biomarker Profile During Virus-induced T1D$376,875
R01 · FY2017 · DK · contact PI
Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy$764,128
R24 · FY2016 · OD · contact PI
Stage-specific Beta Cell Response and Biomarker Profile During Virus-induced T1D$376,875
R01 · FY2016 · DK · contact PI
Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy$748,845
R24 · FY2015 · OD · contact PI
Retrogenic humanized mice for the study of T1D$213,125
R21 · FY2015 · AI · contact PI
Humanized Mouse Avatars for T1D$4,109,951
UC4 · FY2014 · DK · contact PI
Viral Infection Influence on Transplantation Tolerance$1,904,294
P01 · FY2014 · AI · contact PI
Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy$780,422
R24 · FY2014 · OD · contact PI
Mechanisms of Transplantation Tolerance Induction$523,460
P01 · FY2014 · AI · contact PI
Retrogenic humanized mice for the study of T1D$271,354
R21 · FY2014 · AI · contact PI
Mouse and Transplantation Core$145,117
P01 · FY2014 · AI · contact PI
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and Regeneration$99,995
U01 · FY2014 · DK
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and Regeneration$2,014,083
U01 · FY2013 · DK
Viral Infection Influence on Transplantation Tolerance$1,747,633
P01 · FY2013 · AI · contact PI
Mechanisms of Transplantation Tolerance Induction$399,536
P01 · FY2013 · AI · contact PI
Mouse and Transplantation Core$102,584
P01 · FY2013 · AI · contact PI
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and Regeneration$2,064,200
U01 · FY2012 · DK
Viral Infection Influence on Transplantation Tolerance$1,815,308
P01 · FY2012 · AI · contact PI
Mechanisms of Transplantation Tolerance Induction$410,816
P01 · FY2012 · AI · contact PI
Mouse and Transplantation Core$113,863
P01 · FY2012 · AI · contact PI
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and Regeneration$2,089,419
U01 · FY2011 · DK
Viral Infection Influence on Transplantation Tolerance$1,808,769
P01 · FY2011 · AI · contact PI
Adaptive immunity in virus-induced diabetes in BBDR rats$449,672
U01 · FY2011 · AI · contact PI
Mechanisms of Transplantation Tolerance Induction$370,068
P01 · FY2011 · AI · contact PI
Mouse and Transplantation Core$179,517
P01 · FY2011 · AI · contact PI
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and Regeneration$2,089,419
U01 · FY2010 · DK
Viral Infection Influence on Transplantation Tolerance$1,858,792
P01 · FY2010 · AI · contact PI
Adaptive immunity in virus-induced diabetes in BBDR rats$444,205
U01 · FY2010 · AI · contact PI
Mechanisms of Transplantation Tolerance Induction$373,397
P01 · FY2010 · AI · contact PI
Mouse and Transplantation Core$181,894
P01 · FY2010 · AI · contact PI
Adaptive immunity in virus-induced diabetes in BBDR rats$434,416
U01 · FY2009 · AI · contact PI
PILOT AND FEASIBILITY PROGRAM$208,332
P30 · FY2009 · DK · contact PI
Adaptive immunity in virus-induced diabetes in BBDR rats$693,195
U01 · FY2008 · AI · contact PI
Experimental Juvenile Type Diabetes$354,846
R01 · FY2008 · DK · contact PI
PILOT AND FEASIBILITY PROGRAM$177,458
P30 · FY2008 · DK · contact PI
Project 2: Mechanisms of Transplantation Tolerance in NOD Mice$225,357
P01 · FY2007 · DK · contact PI
PILOT AND FEASIBILITY PROGRAM$201,338
P30 · FY2007 · DK · contact PI
Core B: Animal Core$98,650
P01 · FY2007 · DK · contact PI
Genetics of Autoimmunity in BB Rats$333,995
R01 · FY2006 · DK · contact PI
PILOT AND FEASIBILITY PROGRAM$324,750
P30 · FY2006 · DK · contact PI
Genetics of Autoimmunity in BB Rats$332,068
R01 · FY2005 · DK
PILOT AND FEASIBILITY PROGRAM$324,000
P30 · FY2005 · DK
Genetics of Autoimmunity in BB Rats$322,400
R01 · FY2004 · DK
Genetics of Autoimmunity in BB Rats$327,755
R01 · FY2003 · DK
HUMAN HEMOPOIESIS IN NEW SCID MOUSE MODELS$248,766
R01 · FY2003 · DK
PROTHYMOCYTES AND DIABETES MELLITUS IN BB/W RATS$223,640
R01 · FY2003 · DK
GENETICS OF AUTOIMMUNITY IN BB RATS$324,487
R01 · FY2002 · DK
HUMAN HEMOPOIESIS IN NEW SCID MOUSE MODELS$241,520
R01 · FY2002 · DK
PROTHYMOCYTES AND DIABETES MELLITUS IN BB/W RATS$217,127
R01 · FY2002 · DK
INDUCTION OF IMMUNOLGICAL TOLERANCE TO ISLET XENOGRAFTS$180,000
P01 · FY2002 · DK
TOLERANCE AND VIRUS INFECTION IN AUTOIMMUNE DIABETES$0
P01 · FY2002 · AI
GENETICS OF AUTOIMMUNITY IN BB RATS$315,788
R01 · FY2001 · DK
HUMAN HEMOPOIESIS IN NEW SCID MOUSE MODELS$234,487
R01 · FY2001 · DK
PROTHYMOCYTES AND DIABETES MELLITUS IN BB/W RATS$210,803
R01 · FY2001 · DK
INDUCTION OF IMMUNOLGICAL TOLERANCE TO ISLET XENOGRAFTS$180,000
P01 · FY2001 · DK
TOLERANCE AND VIRUS INFECTION IN AUTOIMMUNE DIABETES$0
P01 · FY2001 · AI
GENETICS OF AUTOIMMUNITY IN BB RATS$307,063
R01 · FY2000 · DK
HUMAN HEMOPOIESIS IN NEW SCID MOUSE MODELS$241,654
R01 · FY2000 · DK
TOLERANCE AND VIRUS INFECTION IN AUTOIMMUNE DIABETES$232,754
P01 · FY2000 · AI
PROTHYMOCYTES AND DIABETES MELLITUS IN BB/W RATS$204,663
R01 · FY2000 · DK
INDUCTION OF IMMUNOLGICAL TOLERANCE TO ISLET XENOGRAFTS$147,303
P01 · FY2000 · DK